The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
Jan. 15, 2016
Applicant:
Axiogenesis Ag, Köln, DE;
Inventors:
Heribert Bohlen, Köln, DE;
Kristina Jönsson, Köln, DE;
Andreas Ehlich, Mechernich, DE;
Silke Schwengberg, Düren, DE;
Assignee:
AXIOGENESIS AG, Cologne, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); G01N 33/50 (2006.01); C12N 5/077 (2010.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5014 (2013.01); C12N 5/0657 (2013.01); C12Q 1/025 (2013.01); C12Q 1/6876 (2013.01); G01N 33/502 (2013.01); G01N 33/5008 (2013.01); G01N 33/5023 (2013.01); G01N 33/5026 (2013.01); G01N 33/5061 (2013.01); G01N 33/5073 (2013.01); C12N 2503/02 (2013.01); C12N 2506/02 (2013.01); C12N 2510/00 (2013.01); C12N 2830/008 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/142 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/52 (2013.01);
Abstract
Provided are assay systems for determining the therapeutic or toxic effect of a putative drug based on assaying its activity in cells which have been differentiated in vitro from stem cells, and induced to display a phenotype that resembles a disease to be treated.